Guangdong True Health Medical Technology Development Co., Ltd.
廣東真健康醫療-B
💡 定價範圍HK$119.30–135.40
Offer Price
HK$135.40
Market Cap
HK$48.3B
Listing Date
2026-06-30
Sector
醫療科技
📊 Valuation Analysis
P/S ratio
367.9x
偏高 — 溢價上市醫療科技 sector P/S benchmark: 15x – 30x
Revenue growth (YoY)
577.8%
Gross margin
76.2%
Net margin
-738.5%
Profitability
Loss-making
Fair value range by sector P/S benchmark: HK$5.52 – HK$11.04
💰 Financial Summary (FY2025)
Revenue
RMB0.12B
Prior revenue
RMB0.02B
Gross profit
RMB0.09B
Net profit
RMB-0.90B
Figures in RMB (some companies converted from their prospectus reporting currency — see notes below).
📝 Key Notes
手術機器人，收入極低(FY2025 1,218萬人民幣)，淨虧損9,011萬。
🏢 Company Overview
廣東真健康醫療科技股份有限公司，中國領先的骨科手術機器人研發企業。核心產品「真健康TH-Ortho」為脊柱外科手術導航及機器人輔助系統，集術前規劃、術中導航、機械臂輔助定位於一體，已取得國家藥監局(NMPA)創新醫療器械特別審批資格並完成臨床試驗。在研管線包括關節置換機器人及軟組織穿刺機器人。目標客戶為全國三級及二級醫院的骨科/脊柱外科，目前處於早期商業化階段，收入規模極小，研發及銷售團隊擴張為主要開支。
🔢 Want to adjust the parameters yourself?
Use the IPO valuation calculator to enter a stock code, adjust revenue and share count, and get a fair value range.
⚠️ For educational reference only and not investment advice. IPO pricing, listing dates and financial data are subject to change — always refer to HKEX announcements and the prospectus. Investing involves risk.